Patrick Wijten
Impact in
- Hematology top 10%
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Inflammation biomarkers and pathways
- Immune cells in cancer
Papers in
-
- Platelet Disorders and Treatments 2
-
- Atherosclerosis and Cardiovascular Diseases 1
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 1
- Co-authors
- Albert J. R. Heck (4 shared papers)Arjen Scholten (4 shared papers)Onno B. Bleijerveld (3 shared papers)Mark Roest (2 shared papers)Thijs C. van Holten (2 shared papers)Marjolein Heeres (1 shared paper)Kiki Tesselaar (1 shared paper)Nienke Vrisekoop (1 shared paper)
- Journals
- Blood (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Journal of Proteome Research (1 paper)Frontiers in Pharmacology (1 paper)Redox Biology (1 paper)
- Partner nations
- QatarNetherlandsUnited Kingdom
In The Last Decade
Patrick Wijten
9 papers receiving 319 citations
Peers
Comparison fields: 5 of 65
- Hematology 112
- Immunology 79
- Clinical Biochemistry 6
- Spectroscopy 18
- Infectious Diseases 21
Countries citing papers authored by Patrick Wijten
This map shows the geographic impact of Patrick Wijten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Wijten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Wijten more than expected).
Fields of papers citing papers by Patrick Wijten
This network shows the impact of papers produced by Patrick Wijten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Wijten. The network helps show where Patrick Wijten may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Wijten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 98 | |
| 2 | 2013 | 84 | |
| 3 | 2014 | 62 | |
| 4 | 2020 | 33 | |
| 5 | 2012 | 17 | |
| 6 | 2024 | 14 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 6 | |
| 9 | 2023 | 2 |
About Patrick Wijten
Patrick Wijten is a scholar working on Hematology, Immunology, Clinical Biochemistry, Biotechnology and Neurology, having authored 9 papers that have together received 325 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (2 papers), Microbial Inactivation Methods (1 paper), Algal biology and biofuel production (1 paper), Atherosclerosis and Cardiovascular Diseases (1 paper), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), Dementia and Cognitive Impairment Research (1 paper), Advanced Proteomics Techniques and Applications (1 paper) and Advanced Scientific Research Methods (1 paper). The work is most often cited by research in Hematology (112 citations), Immunology (79 citations), Clinical Biochemistry (6 citations), Spectroscopy (18 citations) and Infectious Diseases (21 citations). Patrick Wijten has collaborated with scholars based in Qatar, Netherlands and United Kingdom. Frequent co-authors include Albert J. R. Heck, Arjen Scholten, Onno B. Bleijerveld, Mark Roest, Thijs C. van Holten, Marjolein Heeres, Kiki Tesselaar, Nienke Vrisekoop, Luke P. H. Leenen and Tamar Tak. Their work appears in journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology, Journal of Proteome Research, Frontiers in Pharmacology and Redox Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.